We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 678

Boulder Public Health Group Advocates Excise Tax on Sugar-Sweetened Beverages
  • Shook Hardy & Bacon LLP
  • USA
  • April 22 2016

Healthy Boulder Kids has submitted to the city of Boulder, Colorado, a draft initiative that would impose on distributors a 2-cent per-ounce excise


New Study Reevaluates Effect of Fat Intake on Cholesterol and Heart Disease Risk
  • Shook Hardy & Bacon LLP
  • USA
  • April 15 2016

A study reevaluating "the traditional diet-heart hypothesis" concludes that replacing dietary saturated fat with vegetable oils lowers serum


FDA steps up issuance of warning letters to cosmetic and dietary supplement companies
  • Shook Hardy & Bacon LLP
  • USA
  • April 1 2015

The Food and Drug Administration (FDA) has issued a number of Warning Letters to cosmetic and dietary supplement companies over the last several


Energy drink makers target new demographic
  • Shook Hardy & Bacon LLP
  • USA
  • August 23 2013

Although the typical energy drink user is reportedly young and male, a recent news source indicates that a new demographic is emerging as a top


Salt Institute Disputes Sodium Recommendations in Federal Dietary Guidelines
  • Shook Hardy & Bacon LLP
  • USA
  • April 15 2016

The Salt Institute has penned an April 11, 2016, letter asking the U.S. Department of Agriculture (USDA) and Department of Health and Human Services


Plain Food Packaging Might Encourage Consumption
  • Shook Hardy & Bacon LLP
  • USA
  • January 8 2016

Plain food packaging for snack foods decreases purchase intention and brand perception but increases actual consumption among some consumers


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Enjoining GM alfalfa deregulation went too far according to U.S. Supreme Court
  • Shook Hardy & Bacon LLP
  • USA
  • June 25 2010

In a 7-1 ruling, the U.S. Supreme Court has determined that a district court erred in enjoining the Animal and Plant Health Inspection Service (APHIS) from even partially deregulating Monsanto’s Roundup Ready alfalfa while the agency takes steps to comply with the National Environmental Policy Act (NEPA


Cooked meats allegedly linked to increased Alzheimer’s risk
  • Shook Hardy & Bacon LLP
  • USA
  • February 28 2014

A new study has concluded that advanced glycation endproducts (AGEs), which occur in heat-processed meat and animal products, can cause brain changes


French company prevails in dispute with FDA over drug-classification ruling
  • Shook Hardy & Bacon LLP
  • USA
  • October 3 2012

A federal court in the District of Columbia has determined that the Food and Drug Administration (FDA) erred when it classified a combination drug-device product as primarily a drug, thus subjecting its French manufacturer to more burdensome regulatory requirements